ArticleOncotarget2016

Analysis of the efficacy and safety of a combined gemcitabine, oxaliplatin and pegaspargase regimen for NK/T-cell lymphoma.

Jing-Hua Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.